ARTICLE | Clinical News
SMART M195 Antibody: Phase III trial update
November 13, 2000 8:00 AM UTC
Protein Design Labs Inc. (PDLI), Fremont, Calif. Product: SMART M195 Antibody Business: Cancer Therapeutic category: Antibody, Cytotoxic Target: CD33 Description: Humanized monoclonal antibody agains...